Dosage of an antithyroid drug, methimazole.Administration frequency per day.
نویسندگان
چکیده
منابع مشابه
Antithyroid drug-induced agranulocytosis.
Antithyroid drugs are widely used to treat hyperthyroidism, especially Graves' disease, but they tend to cause agranulocytosis, which increases the mortality rate. Granulocyte colony-stimulating factor decreases the duration of recovery from agranulocytosis. We retrospectively studied cases of antithyroid drug-induced agranulocytosis over the past 10 years in a northern Taiwan medical center. A...
متن کاملAntithyroid drug-induced agranulocytosis.
Thyrotoxicosis is a common endocrine disorder. Antithyroid drug therapy is the standard treatment for this disease, especially in young women of reproductive age. A serious side effect of antithyroid drug use, however, is agranulocytosis. We report on two patients with antithyroid drug-induced agranulocytosis. Both patients presented with fever and severe neutropenia. The administration of gran...
متن کاملFrequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy
The frequency and types of adverse events after initial antithyroid drug (ATD) therapy during pregnancy have never been reported, nor has whether the frequency of adverse events is the same as among nonpregnant subjects ever been investigated. We investigated retrospectively the frequency of adverse events after initial ATD administration to previously untreated Graves' disease (GD) patients du...
متن کاملAn Evaluation of Per-Chip Nonuniform Frequency Scaling on Multicores
Concurrently running applications on multiprocessors may desire different CPU frequency/voltage settings in order to achieve performance, power, or thermal objectives. Today’s multicores typically require that all sibling cores on a single chip run at the same frequency/voltage level while different CPU chips can have non-uniform settings. This paper targets multicorebased symmetric platforms a...
متن کاملDrug Dosage Formulations
The discovery and development of a new drug can be a lengthy and expensive business (Fig. 1). The starting point is the active compound as synthesized by the medicinal chemist and screened by the pharmacologist. There then follows a series of complex tests and evaluations to produce a satisfactory formulation and sufficient data for presentation to regulatory authorities such as the Committee o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
سال: 1995
ISSN: 1882-8272,0388-1601
DOI: 10.3999/jscpt.26.179